Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|February 24, 2006
Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) geneDavid A Boyd, Mark A Miller, Michael R Mulvey
The Journal of Antimicrobial Chemotherapy|August 17, 2004
Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operonDavid A Boyd, Pamela Kibsey, Diane Roscoe, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2019
Two Hypervirulent Klebsiella pneumoniae Isolates Producing a blaKPC-2 Carbapenemase from a Canadian PatientLaura F Mataseje, David A Boyd, Michael R Mulvey, et al.
Microbes and Infection|May 23, 2006
The genetics of Salmonella genomic island 1Michael R Mulvey, David A Boyd, Adam B Olson, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2008
Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanLDavid A Boyd, Barbara M Willey, Darlene Fawcett, et al.
Emerging Infectious Diseases|January 4, 2011
New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, CanadaMichael R Mulvey, Jennifer M Grant, Katherine Plewes, et al.
Journal of Medical Microbiology|October 24, 2018
Characterization of a colistin-resistant Salmonella enterica 4,[5],12:i:- harbouring mcr-3.2 on a variant IncHI-2 plasmid identified in CanadaMichael R Mulvey, Amrita Bharat, David A Boyd, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2019
Identification of a novel metallo-β-lactamase, CAM-1, in clinical Pseudomonas aeruginosa isolates from CanadaDavid A Boyd, Luiz F Lisboa, Robert Rennie, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2007
Salmonella genomic island 1 (SGI1), variant SGI1-I, and new variant SGI1-O in proteus mirabilis clinical and food isolates from ChinaDavid A Boyd, Xiaolu Shi, Qing-hua Hu, et al.
Pageof 22